Koers Vivimed Labs Ltd NSE India S.E.
Aandelen
INE526G01013
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- INR | - |
26/02 | Vivimed Labs CFO neemt ontslag | MT |
14/02 | Vivimed Labs Limited rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 31 december 2023 | CI |
Omzet 2022 | 2,39 mld. 28,73 mln. 26,48 mln. | Omzet 2023 | 1,88 mld. 22,65 mln. 20,88 mln. | Marktkapitalisatie | 547 mln. 6,59 mln. 6,07 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -677 mln. -8,15 mln. -7,52 mln. | Nettowinst (verlies) 2023 | -3,28 mld. -39,56 mln. -36,47 mln. | EV/omzet 2022 | 1,98 x |
Nettoschuld 2022 | 3,52 mld. 42,35 mln. 39,04 mln. | Nettoschuld 2023 | 3,77 mld. 45,43 mln. 41,88 mln. | EV/omzet 2023 | 2,3 x |
K/w-verhouding 2022 |
-1,78
x | K/w-verhouding 2023 |
-0,17
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 74,35% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Santosh Varalwar
CEO | Chief Executive Officer | 62 | 09-11-89 |
Compliance Officer | - | - | |
S. G. Saurabh
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Santosh Varalwar
CEO | Chief Executive Officer | 62 | 09-11-89 |
Sandeep Varalwar
BRD | Director/Board Member | 55 | 23-01-08 |
Subhash Varalwar
BRD | Director/Board Member | 76 | 09-11-89 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,51% | 727 mld. | |
+33,05% | 599 mld. | |
-6,23% | 354 mld. | |
+18,78% | 328 mld. | |
+1,35% | 277 mld. | |
+16,00% | 243 mld. | |
+8,09% | 205 mld. | |
-5,77% | 203 mld. | |
+6,19% | 164 mld. |